Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride lowers PSA levels in men, certain factors increase testicular cancer risk, and current guidelines for penile cancer may lead to unnecessary surgeries.

Cancer rates are increasing in developed countries, with estrogen, aging, low vitamin D3, and HPV infection as common causes.

Smoking harms skin health, causing slower wound healing, more wrinkles, and worsening some skin conditions, but may protect against certain others.

The document concludes that understanding health requires considering evolutionary perspectives on reproductive fitness, and recognizing the complexity of factors like diet, testosterone, and sexual orientation.

B2m-free HLA variants may be a new class of HLA important in immune responses and diseases.

HIV patients with lower CD4 T cell counts often have more skin problems.

Skin doctors should know about skin and kidney disease links to prevent serious kidney problems.

Lichen planopilaris in men often involves scalp redness and itching, with some also having hair loss, mucosal lichen planus, or thyroid disease, and treatment improved symptoms in nearly half of the cases.

Urologists should monitor mental health in patients taking finasteride due to potential links to suicidal thoughts, adjusting dosage or stopping use if necessary. More research is needed to confirm if finasteride causes these thoughts.

Baldness, especially at the front, may lower the risk of testicular cancer by 31%, but its link to prostate cancer is unclear.

Oral finasteride and dutasteride may negatively affect erectile function in rats.

A young man with high-grade prostate cancer had successful surgery and good recovery, highlighting the need for awareness in younger men.

Finasteride reduces prostate cancer risk but may increase high-grade tumors and has side effects; biopsy methods have similar outcomes; psychosocial factors affect sexual recovery post-surgery.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

The conclusion is that individualized treatment and proper medication use are crucial in men's health, with specific recommendations for ED, BPH, and prostate cancer management.

Targeted cancer therapies often cause serious skin problems that need careful management.

Long-term use of a certain medication can worsen erectile function in aged rats by damaging penile muscle cells.

New treatments like nanotechnology show promise in improving skin cancer therapy.

Early detection and skin biopsies are crucial for treating skin cancer and diagnosing various skin conditions.

Androgen deprivation therapy for prostate cancer can cause sexual, physical, and psychological side effects, and doctors should manage these carefully.

A woman died from cancer that spread from a long-standing cyst on her abdomen.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

5-alpha reductase inhibitors may have additional effects on cancer, mental health, heart health, and hormone levels beyond treating prostate enlargement.

Androgen receptors are key for development and health, affecting conditions like prostate cancer and male pattern baldness.

Lichen Planus is a less common condition affecting skin and mucous membranes, with various types and associated risk factors, challenging to diagnose, significantly impacts life quality, and may have a risk of cancerous changes in oral lesions.

The skin's layers protect, sense, and regulate the body's internal balance, but can be prone to cancer.